Franklin Resources’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-439,809
Closed -$1.76M 2360
2022
Q3
$1.76M Sell
439,809
-8,514
-2% -$64.6K ﹤0.01% 1388
2022
Q2
$5.07M Buy
448,323
+192,734
+75% +$2.31M ﹤0.01% 1107
2022
Q1
$4.15M Buy
255,589
+217
+0.1% +$5.56K ﹤0.01% 1204
2021
Q4
$12.1M Buy
255,372
+1,393
+0.5% +$83.6K ﹤0.01% 1005
2021
Q3
$18.4M Buy
253,979
+17,712
+7% +$1.28M 0.01% 910
2021
Q2
$19.8M Sell
236,267
-50,405
-18% -$3.33M 0.01% 859
2021
Q1
$13.9M Buy
286,672
+251,706
+720% +$13.7M 0.01% 916
2020
Q4
$1.65M Hold
34,966
﹤0.01% 1327
2020
Q3
$1.64M Hold
34,966
﹤0.01% 1266
2020
Q2
$1.05M Hold
34,966
﹤0.01% 1268
2020
Q1
$455K Buy
+34,966
New +$437K ﹤0.01% 1330

Other funds holding NBP

Franklin Resources's NBP Position: Q4 2022 in Review

Franklin Resources sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2022, closing a stake of 439,809 shares — an estimated $1.76M sold.

Franklin Resources first reported a position in NBP in Q1 2020 and held it in 11 quarters. The position peaked at $19.8M in Q2 2021. 69 funds tracked by Wall St. Rank hold NBP as of Q4 2022.

  • Franklin Resources reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • Franklin Resources sold 439,809 NovaBridge Biosciences American Depositary Shares shares in Q4 2022, an estimated $1.76M.
  • Franklin Resources first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2020 and held it in 11 quarters.
  • Franklin Resources's NovaBridge Biosciences American Depositary Shares position peaked at $19.8M in Q2 2021.
  • 69 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2022.

Based on Franklin Resources's 13F filing for Q4 2022, filed 10 Feb 2023.